Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

You are here

Home » Atezolizumab (Tecentriq)
Atezolizumab (Tecentriq)
Connect with this vendor - Learn about this product
Add to Favourite List
Request Info

Atezolizumab (Tecentriq)

GNH India
Category: 
Pharma & Supplements
Drugs

Each vial contains Atezolizumab 1200 mg
Tecentriq (atezolizumab) is a programmed death-ligand 1 (PD-L1) blocking antibody indicated for the treatment of patients with advanced urothelial carcinoma and patients with metastatic non-small cell lung cancer (NSCLC).

  • Presentation: Injection
  • Strength:  1200 mg/ 20 ml  
  • Pack Size: 1 vial of 20ml
  • Pack Insert: Yes
  • Manufacturing License: 1048
View this product at gnhindia.com
We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy and Cookie Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree